Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
Lipid-lowering therapy for primary prevention of premature atherosclerotic coronary artery disease: Eligibility, utilization, target achievement, and predictors of initiation
Vikulova DN, Skorniakov IS, Bitoiu B, Brown C, Theberge E, Fordyce CB, Francis GA, Humphries KH, Mancini GBJ, Pimstone SN, Brunham LR